Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Dyne Therapeutics (NASDAQ:DYN) traded higher in the premarket on Wednesday after BMO Capital Markets launched its coverage with an Outperform recommendation and a $50 per share target, citing the ...

BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...

BMO Capital analyst Kostas Biliouris initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $50 price target The firm ...

A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...

BMO Capital lowered the firm’s price target on Lyft (LYFT) to $15 from $18 and keeps a Market Perform rating on the shares. The company’s Q1 Bookings guidance growth of 10%-14% is below its ...

The S&P 500 has never lost ground in the back half of the year after advancing between 10% and 15% in the first six months, according to BMO Capital Markets, citing data since 1950. The Montreal ...

https://www.tipranks.com/news/the-fly/mongodb-price-target-lowered-to-240-from-275-at-scotiabank BMO Capital lowered the firm’s price target on DoubleVerify (DV) to ...

Whiplash from continually changing developments on tariffs has lashed investor sentiment, said Douglas Porter, chief economist at BMO Capital Markets, who noted stocks have been pressured for most of ...

Overall, the low yields and monthly fees offered by Wells Fargo on its checking and savings account options are weaker than BMO. Capital One has only 300 branches, but has a larger ATM network ...